Preoperative Hepatic Arterial Infusion Chemotherapy

NCT00522509 · Status: UNKNOWN · Type: OBSERVATIONAL

Last updated 2007-08-29

No results posted yet for this study

Summary

To assess the feasibility and results of liver resection after preoperative hepatic artery infusion (HAI) chemotherapy with FUDR.

Conditions

  • Colorectal Liver Metastases

Interventions

DRUG

Floxuridine FUDR

Sponsors & Collaborators

  • IRCCS San Raffaele

    lead OTHER

Principal Investigators

  • Luca Aldrighetti, M.D, PhD · Department of Surgery - Liver Unit, Scientific Institute San Raffaele,

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1995-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00522509 on ClinicalTrials.gov